Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Synthesis and PTP1B inhibition of 1,2-naphthoquinone derivatives as potent anti-diabetic agentsJin Hee Ahn, Sung Yun Cho, Jae Du Ha, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivativesSung Yun Cho, Ji Yoen Baek, Sang Sub Han, et al.
Biochemical and Biophysical Research Communications|July 15, 2015
Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteinsChung Hyo Kang, Jeong In Yun, Kwangho Lee, et al.
Bioorganic & Medicinal Chemistry|December 30, 2015
Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitorsRaghavendra Achary, Jeong In Yun, Chi Min Park, et al.
European Journal of Medicinal Chemistry|December 5, 2016
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202RGangadhar Rao Mathi, Chung Hyo Kang, Heung Kyoung Lee, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2006
Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitorsJin Hee Ahn, Seung Jun Kim, Woul Seong Park, et al.
Cancer Research|April 29, 2021
Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and ChemoresistanceMiso Park, Ji Won Kim, Kyu Min Kim, et al.
European Journal of Medicinal Chemistry|January 27, 2019
A novel cereblon modulator for targeted protein degradationSung Ah Kim, Ara Go, Seung-Hyun Jo, et al.
Cancers|June 19, 2020
Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in <i>MET</i>-Addicted CancerJooseok Kim, Kyung Eui Park, Yoo-Seong Jeong, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2013
Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatmentChi Hoon Park, Hyeonjeong Choe, In-Young Jang, et al.
Pageof 5